Acumen Research and Consulting latest published report titled “Thoracic Drainage Devices Market, Global Industry Analysis, Market Size, Opportunities and Forecast, 2020 - 2027”.
LOS ANGELES, Dec. 09, 2020 (GLOBE NEWSWIRE) -- Global thoracic drainage devices market is expected to reach the market value of around US$ 900 Mn by 2027 and is anticipated to grow at a CAGR of around 4% in terms of revenue during the forecast period 2020 – 2027.
Request COVID-19 Impact on Dental Health Market@ https://www.acumenresearchandconsulting.com/request-sample/2300
The chest drain, thoracic catheters, intercostal drain, chest tube and thoracotomy tubes are all destroyed. It is a surgical instrument intended for the evacuation of air, gases, and some chemicals from the pleural space and chest mediastinum. Thoracic drainage systems consist primarily of transparent plastics like soft silicon or PVC and depending on the product, their sizes differ considerably. These systems are attached to a local chest drainage device, allowing the drainage of fluid or air and preventing the entrance of air or moisture into the pleural region of the chest during the operation. The chest drainage instruments are mainly used for signs of illness such as pneumothorax, heart surgery and pleural effusion.
North America to Corner the Thoracic Drainage Devices Market
There are significant prospects for industry participants, as the governments of many countries are gradually taking healthcare measures, both monetary and awareness-based, with North America at the forefront. The US Food and Drug Administration (FDA) emphasis on premium technologies is expanding the research and development envelope, opening up compensatory potential to expand the exclusivity of industry leader portfolios. Furthermore, the high concentration of clinics, operating centre and ambulatory facilities, among others, ensures that industry leaders have a long-term shot. In 2019, the share in North America will be ~ 30%, while developing countries in the Asian Pacific are expected to rise at an accelerated pace in terms of attractiveness during 2019-2027, following the pathways of developed countries.
View Table Of Content of this Report@ https://www.acumenresearchandconsulting.com/thoracic-drainage-devices-market
Market dynamics
Owing to factors such as rising patient demand for minimally invasive surgery, a high incidence of cardiovascular disorders, an elevated burden of sudden pneumothorax and rising medical insurance coverage triggering acceptance of thoracic drainage devices, the demand for thoracic drainage devices is expected to expand dramatically over the next few years. A significant concern in the health of a vast population worldwide is cardiovascular disease. The major causes of coronary diseases such as stroke, stenosis, atresia and regurgitation are elevated blood pressure, diabetes and obesity. Growing numbers of open heart surgical operations due to poor health, lack of exercise, overweight and smoking provides prospects for growth in the market of thoracic drainage products.
Thoracic Surgery & Pulmonology Segment is Expected to Register a Significant Growth in the Forecast Period
By Application, the market has been segmented into Cardiac Surgery, Oncology & Pain Management, Thoracic Surgery & Pulmonology, Emergency General Intensive Care and Others. Thoracic and pulmonology diseases are very prevalent and in contrast with other fields, the incidence of these disorders is growing, which is expected to continue throughout the prediction period. In the United States, about four thousand cardiovascular surgeons conducted over 530,000 cases in the census and the Society of Thoracic Surgery in 2010. By 2030, about 3,000 cardiothoracic surgeons are projected to be available for about 854,000 cases. On account of fast population growth the average case load per surgeon will rise from 135 by 2010 to 299 by 2035. Pneumothorax, pleural effusion and conditions of empyema are treated with thoracic drainage instruments. Moreover, increased public knowledge and a wide pool of patients both add to the growth of the market studied.
Some of the industry players include MAQUET Holding B.V. & Co. KG., Vygon, Cook, Teleflex Incorporated, C. R. Bard, Inc., Smiths Medical, Utah Medical Products, Inc., Sinapi Biomedical, ATMOS MedizinTechnik GmbH & Co. KG, Medela AG, and others.
Browse Acumen Upcoming Reports@ https://www.acumenresearchandconsulting.com/forthcoming-reports
Recent Developments
- In June 2019, Getinge announced a medical device recall for its custom tubing kits for heart lung machines.
- ATMOS MedizinTechnik GmbH & Co. KG provides the Thorax and the Thorax ATMOS S201 and the Thorax C 051 Thorax digitalization. The new versions of these instruments are powered by batteries. Those instruments allow patients to be activated faster and ensure greater therapeutic protection.
INQUIRY BEFORE BUYING@ https://www.acumenresearchandconsulting.com/inquiry-before-buying/2300
Buy this premium research report – https://www.acumenresearchandconsulting.com/buy-now/0/2300
Would like to place an order or any question, please feel free to contact at sales@acumenresearchandconsulting.com | +1 407 915 4157
For Latest Update Follow Us:
https://www.facebook.com/acumenresearchandconsulting
https://www.linkedin.com/company/acumen-research-and-consulting/